Skip to main content
. 2022 Oct 1;10(10):2462. doi: 10.3390/biomedicines10102462

Table 3.

The changes of serum biomarkers in patients with COVID-19.

Day 1 Day 7 Day 28 p-Value
TNFα, pg/mL 21.9 (17.2–26.6) 24.2 (19.2–27.6) 19.5 (16.6–23.1) p < 0.001 *
IL-1β, pg/mL 21.2 (12.5–26.9) 23.6 (15–28.4) 18.3 (12.5–24.7) p < 0.001 #
Pentraxin 3, pg/mL 6643 (3852–11,148) 3369 (2179–5007) 1839 (1111–2597) p < 0.001 *
Chemerin, pg/mL 8916 (6661–10,773) 7359 (5705–9533) 9324 (7371–11,033) p < 0.001 #
Adiponectin, ng/mL 6559 (4640–13,041) 7134 (5170–14,854) 8455 (6080–19,191) p < 0.001 *
Resistin, pg/mL 21,600 (14,123–29,587) 5586 (11,257–21,676) 11,629 (8415–15,690) p < 0.001 *
Angiopoietin2, pg/mL 1502 (1070–2247) 1256 (907–1678) 1662 (1173–2125) p < 0.001 #
Leptin, pg/mL 1824 (989–3981) 1569 (858–3153) 1372 (820–2652) p < 0.001 *

The Friedman ANOVA by ranks with post-hoc analysis. The results are shown as medians (IQR). p < 0.001 for the difference between the mean ranks; p < 0.05 for post-hoc analysis, * day 1 vs. day 7, day 7 vs. day 28, day 1 vs. day 28; # day 1 vs. day 7, day 7 vs. day 28. COVID-19, coronavirus disease 2019; TNFα, tumor necrosis factor alfa; IL-1β, interleukin 1 beta.